The Partnerships in Clinicals Trials conference brings together more than 1,300 industry specialists for four days of high-level idea exchange and innovation. It has been around for 23 years now, and in that time, the industry has seen a lot of positive change; however, much more is needed.
This year, I had the opportunity to serve on the conference’s advisory panel, and I look forward to seeing how many presentations and workshops will be focused on new approaches and true innovation.
Here are just of few potential highlights:
Partnering with Patients Panel
Conversations tend to be most inspiring and productive when they bring together the perspectives of a variety of stakeholders in the clinical trial process. This panel discussion will include several patient advocates and a few leaders from the clinical research industry. Among them will be our own Jeff Kasher, leader of Clinical Innovation and Implementation at Eli Lilly, and Lane Rasberry, a clinical trial participant and open data advocate who authored a guest post on our blog last summer. The panel will be moderated by Roni Zeiger, a practicing physician, forner chief health strategist Google, and founder of Smart Patients. I’m looking forward to hearing this group’s ideas on how the pharma industry can “get it right” when it comes to putting the patient at the center of clinical trials.
Patient Engagement App Challenge Winners
Last winter, in partnership with UBC, Enlight Biosciences and the Partnerships in Clinical Trials team we challenged the healthcare and health IT communities to help transform the clinical trial experience for patients. Their mission was to design apps that would educate, engage and empower those enrolled in clinical studies. We were pleased to receive many smart and inspiring submissions. On Tuesday, the four award-winning teams will unveil their winning apps. Our hope is that this challenge will help provide patients with better options for managing their clinical trial experiences, and will help to usher in even more ideas that will further us down the path to truly patient-friendly trials.
Enabling Patients to Match to Clinical Trials
We first announced our collaboration with Novartis and Pfizer last November. Our overall mission is do a better job of informing patients, providers, and caregivers about clinical research opportunities. To that end, we’re currently focused on enabling patient-centric software providers to build better resources for patients through an open API with clear and consistent study “Target Profiles.” Much progress has been made in the last few months, and I’m looking forward to joining Joris van Dam from Novartis and David Leventhal from Pfizer to share the latest results of this pilot program.
Follow Along with Us
What I’m most looking forward to from this conference is learning even more about how patients, CROs, pharma and other stakeholders can work together to provide better opportunities in clinical research. We’d love for you to follow along with the conference on social media and tell us your thoughts. We’ll be sharing as much as we can in real-time through @Lilly_COI on Twitter. You can also follow the conference hashtag #PCTUS for updates from the conference organizers and other attendees. And, soon after we return, we’ll post an overview of the conference with our key takeaways here on the blog.